U.S. Construction Stock News

NYSE:SMG
NYSE:SMGChemicals

Scotts Miracle Gro (SMG) Stock Could Be 49% Overvalued After Brand And AI Push

Scotts Miracle-Gro (SMG) is stepping up its SMG 2.0 shift with a new executive vice president and chief brand officer, Nick Miaritis, along with an expanded AI-enabled Kinaxis partnership to tighten supply chain planning. See our latest analysis for Scotts Miracle-Gro. Scotts Miracle-Gro’s recent leadership and supply chain moves come as the stock shows a mixed picture, with a 9.35% 1-month share price return and share price performance over the past 90 days declining 3.22%. Over longer...
NasdaqGS:GOOGL
NasdaqGS:GOOGLInteractive Media and Services

Alphabet (GOOGL) Expands AI Reach With HSBC, MediaTek And Waymo Safety Push

Alphabet (NasdaqGS:GOOGL) and HSBC announced a multi year partnership to apply AI across more than 200 use cases across the bank’s global operations. Google agreed to work with MediaTek on next generation TPU chip technology and supported a US$3.2b financial guarantee linked to the Lake Mariner AI data center project. Waymo, Alphabet’s self driving unit, launched its first nationwide public safety TV campaign to address consumer concerns about autonomous vehicles. These moves show Alphabet...
NasdaqGS:FSLR
NasdaqGS:FSLRSemiconductor

Does First Solar's (FSLR) Record Quarter and Cautious Outlook Reveal a New Risk Balance?

Earlier this year, First Solar reported record first‑quarter revenue and margin expansion, driven in part by strong sales in India and adjusted EBITDA that exceeded expectations, even as its full‑year outlook lagged peers. The combination of robust quarterly execution and comparatively cautious guidance has sharpened attention on how First Solar balances near‑term performance with longer‑term earnings visibility and risk. We’ll now examine how First Solar’s record quarterly revenue and...
NYSE:BIRK
NYSE:BIRKLuxury

Does Birkenstock’s Profitability Momentum and Supportive Sentiment Shift the Bull Case For BIRK?

In recent days, Birkenstock Holding plc reported year-over-year increases in revenue and net profit alongside high operating efficiency and a stable financial health score. At the same time, a generally favorable analyst stance and mixed but leaning-positive technical indicators have reinforced investor attention on Birkenstock within the consumer cyclical sector. Next, we will examine how Birkenstock’s stronger profitability profile may influence its broader investment narrative for...
NasdaqGS:NSIT
NasdaqGS:NSITElectronic

Is Insight’s New AI-Driven Managed Security Offering Altering The Investment Case For Insight Enterprises (NSIT)?

Earlier this week, Insight Enterprises launched Insight Managed Exposure Defense, a bundled managed security service aimed at helping organizations counter AI-driven cyber vulnerabilities with continuous threat exposure management, patching, and detection capabilities. At the same time, JPMorgan’s upgrade of Insight Enterprises to Neutral, citing strong enterprise demand and cloud growth, highlights how the new security offering fits into a broader shift toward higher-margin, service-led IT...
NYSE:BRBR
NYSE:BRBRPersonal Products

Can BellRing (BRBR) Use Buybacks To Offset Margin Pressure In A Crowded Protein Market?

In recent months, BellRing Brands has reported revenue stagnation and margin compression amid rising input costs and tougher competition, even as it retains a leading position in the ready-to-drink protein shake market. Alongside this pressure, investors are focused on BellRing’s large US$600 million share repurchase authorization and the potential impact of future industry consolidation on its already entrenched market share. We’ll now examine how BellRing’s margin pressure, yet sizable...
NasdaqGS:TWST
NasdaqGS:TWSTBiotechs

Is Twist Bioscience’s (TWST) New ATM Program Quietly Reframing Its AI Genomics Investment Story?

In June 2026, Twist Bioscience filed an omnibus shelf registration covering common and preferred stock, debt, warrants, and units, and separately registered a US$200,000,000 at-the-market follow-on equity offering of its common shares. At the same time, Twist drew fresh attention from Osterweis Opportunity Fund for its role in liquid biopsy and as an outsourced wet lab for AI genomics, underscoring how its synthetic DNA platform is being used at the intersection of genomics and artificial...
NYSE:AIN
NYSE:AINMachinery

The Bull Case For Albany International (AIN) Could Change Following Enzyme-Based Textile Recycling Breakthrough

Albany International Corp. recently reported past progress in its collaboration with Sweden-based Cyclezyme AB on enzyme-based recycling of polyester and polyamide industrial textiles, including successful depolymerization trials and nylon-degrading enzyme development. This work highlights Albany’s push into advanced circular materials solutions, targeting hard-to-recycle industrial textiles where current options for closed-loop recycling are limited. We’ll now explore how this enzyme-based...
NYSE:PBI
NYSE:PBICommercial Services

The Bull Case For Pitney Bowes (PBI) Could Change Following A Surge In Institutional Ownership

In recent days, Pitney Bowes reported a very large level of institutional shareholding in its stock, led by bigger positions from LSV Asset Management and Goldman Sachs, even as its latest quarter showed weaker revenue and a sharp drop in net profit. This combination of heavier institutional involvement and strong technical momentum, despite fragile financial health, highlights a sharp split between trading signals and underlying fundamentals. Next, we’ll examine how the surge in...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Fastly (FSLY) Stock Could Be 260.2% Overvalued After Skyfire Partnership

Fastly (FSLY) is in focus after announcing a partnership with Skyfire that integrates identity and payment-backed credentials into its edge cloud platform, targeting secure, real-time verification and monetization of AI agent traffic. See our latest analysis for Fastly. Fastly’s recent partnership news comes after a sharp setback over the past quarter, with a 90 day share price return down 36.52%. However, a strong year to date share price return of 75.66% and 1 year total shareholder return...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

3 Consumer Stocks With Earnings Growth And Funding Risk

Geopolitics, central bank shifts, and a surprise box office hit are all feeding into the same question for investors right now: which consumer-focused stocks might be better positioned for the next phase of market sentiment and which might be more exposed to the risks. This article looks at how easing Middle East tensions, fresh signals from the Federal Reserve after Alan Greenspan’s passing, political change in the U.K., and the strong “Toy Story 5” performance could matter for larger...
NYSE:MOH
NYSE:MOHHealthcare

3 US Defensive Stocks With Strong Margins And Essential Healthcare Demand

Markets are watching the Supreme Court and the Federal Reserve almost as closely as earnings reports right now, as questions over central bank independence and possible political pressure on monetary policy add a fresh layer of risk for portfolios. When trust in the Fed is in focus, many investors look again at large U.S. defensive stocks that may offer relatively steadier business profiles if volatility picks up. This article explains how that backdrop could influence your positioning and...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

CrowdStrike Holdings (CRWD) Stock Could Be 7.5% Overvalued After Falcon AI Security Updates

CrowdStrike Holdings (CRWD) is back in focus after a string of AI and cloud security updates to its Falcon platform, including new detection, response, and identity tools tied closely to Amazon Web Services. See our latest analysis for CrowdStrike Holdings. CrowdStrike Holdings sits at a US$684.86 share price after a strong run, with a 90 day share price return of 74.27% and a 1 year total shareholder return of 39.25%, hinting that momentum has been building rather than fading. If...
NasdaqGS:MRX
NasdaqGS:MRXCapital Markets

Marex Group (MRX) Stock Could Be 14% Overvalued After Board Appointment

Board appointment puts Marex Group (NasdaqGS:MRX) governance in focus Marex Group (NasdaqGS:MRX) has drawn fresh attention after appointing fintech entrepreneur and former investment banker Georges Assi to its Group Board and Risk Committee, a move that highlights the company’s focus on credit and fixed income expertise. Assi currently leads Sigma Lending, a fintech lender he founded in 2023 that provides UK small and medium sized enterprises with working capital through technology enabled...
NYSE:LXP
NYSE:LXPIndustrial REITs

Rising Institutional Stakes and Fresh Dividends Might Change The Case For Investing In LXP Industrial Trust (LXP)

LXP Industrial Trust recently declared a regular common share dividend of US$0.70 per share for the June 2026 quarter and a US$0.8125 Series C preferred dividend, both payable to shareholders of record on their respective cut-off dates. Alongside these payouts, institutional ownership has risen to a very large proportion of the share base, with major investors like BlackRock and PGIM Fixed Income increasing their holdings, coinciding with fresh positive sector commentary from Raymond...
NasdaqGS:FCFS
NasdaqGS:FCFSConsumer Finance

FirstCash Holdings (FCFS) Stock Can Its Valuation Hold Up After Strong Quarterly Results

Fresh attention is turning to FirstCash Holdings (FCFS) after recent quarterly results showed strong year-over-year revenue and profit growth, alongside high institutional ownership and technical indicators that point to improving sentiment in the stock. See our latest analysis for FirstCash Holdings. At a share price of $227.05, FirstCash Holdings has logged a 15.65% 90 day share price return and a 44.82% year to date share price return, contributing to a 76.19% 1 year total shareholder...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

FDA Alignment on Axpaxli and New CFO Might Change The Case For Investing In Ocular Therapeutix (OCUL)

Ocular Therapeutix has confirmed that interim Chief Financial Officer Jason Robins has been appointed as permanent CFO and that it reached alignment with the US FDA to submit a New Drug Application for its Axpaxli injection for wet age-related macular degeneration, which it plans to file in the fourth quarter of 2026. This combination of regulatory clarity for Axpaxli and continuity in financial leadership further defines how Ocular Therapeutix is organizing around its lead retinal asset and...
NYSE:RSI
NYSE:RSIHospitality

Rush Street Interactive (RSI) Stock Could Be 3.6% Undervalued After Strong Earnings Beat

Rush Street Interactive (RSI) is back in focus after quarterly earnings significantly exceeded analyst expectations, with revenue and net profit posting strong year over year growth and the stock continuing to outperform its industry peers. See our latest analysis for Rush Street Interactive. At a share price of $29.09, Rush Street Interactive has seen a 31.27% 3 month share price return and a 50.65% year to date share price return. The 1 year total shareholder return of 105.44% sits...
NYSE:ETR
NYSE:ETRElectric Utilities

Entergy (ETR) Stock Could Be 9% Undervalued as $40b Investment Plan Comes Into Focus

Entergy (ETR) continues to draw investor attention after recent share price moves, prompting a closer look at how its current valuation aligns with fundamentals such as revenue, net income and longer term total return performance. See our latest analysis for Entergy. Over the past year, Entergy’s share price return has been strong and the 1 year total shareholder return of 37.9% and 5 year total shareholder return of 159.4% indicate sustained momentum. This frames today’s US$111.11 level...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Viavi Solutions (VIAV) Stock Could Be 26.8% Undervalued After PCI SIG Testing Win

Viavi Solutions (VIAV) is back on investor radars after its Xgig PCIe 6.0 testing platform secured Gold Suite acceptance from PCI-SIG, alongside a fresh TETRA MS simulator upgrade for its CX300 service monitor. See our latest analysis for Viavi Solutions. The recent product news arrives after a sharp pullback, with Viavi Solutions’ share price down 3.20% over one day and 12.73% over seven days, yet still showing a 31.25% 90 day share price return and a very large 1 year total shareholder...
NasdaqGS:POOL
NasdaqGS:POOLRetail Distributors

How Investors May Respond To Pool (POOL) Leaving The S&P 500 Equal Weight Index After Solid Results

Pool Corporation’s recent removal from the S&P 500 Equal Weighted Index followed a period in which it reported higher Q1 2026 net sales and operating income. This index exclusion, coming soon after solid operational figures, highlights how benchmark membership can influence investor behavior beyond reported fundamentals. We’ll now examine how Pool’s exit from the S&P 500 Equal Weighted Index may influence its investment narrative and longer-term positioning. We've uncovered the 8 dividend...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Apple (AAPL) Stock Could Be 63% Overvalued After Chip Cost Pressures And Intel Deal

Apple (AAPL) is under fresh scrutiny after CEO Tim Cook said rising memory and storage chip costs are forcing product price increases, while the company moves to partner with Intel on US based chip design and manufacturing. See our latest analysis for Apple. Apple shares trade at US$298.01, with a 90 day share price return of 18.43% and a year to date share price return of 9.96%. The 1 year total shareholder return of 48.48% reflects longer term momentum around its AI initiatives, regulatory...
NYSE:ESI
NYSE:ESIChemicals

Element Solutions (ESI) Stock Could Be 3% Undervalued as AI Demand Lifts the Narrative

Element Solutions (ESI) has drawn investor attention after a recent stretch of strong share performance, with the stock up 13% over the past month and 36% over the past 3 months. See our latest analysis for Element Solutions. Looking beyond the recent rally, Element Solutions has delivered a 77.22% year to date share price return. Its 1 year total shareholder return of 111.52% and 3 year total shareholder return of 158.26% point to strong, sustained momentum. If you are reviewing Element...
NasdaqGM:FIVN
NasdaqGM:FIVNSoftware

Five9 (FIVN) Stock Could Be 29% Undervalued After Its Recent Pullback

Five9 (FIVN) has drawn fresh attention after recent trading left the stock down about 15% over the past month, even as its past 3 months performance shows a gain of roughly 29%. See our latest analysis for Five9. At a latest share price of $19.40, Five9’s 7 day share price return has fallen 6.12% and its 1 year total shareholder return is down 26.95%. This comes after a stronger 90 day share price return of 29.04%, so recent momentum looks weaker. If you are weighing up what else to add to...